Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation

Anthony P. Sampson, Emilio Pizzichini, Hans Bisgaard, Redwan Moqbel, Marc Peters-Golden, Stephen Peters, Mark Chang Hwa Liu, Qutayba Hamid, Jonathan Edelman

Research output: Contribution to journalArticle

Abstract

The understanding that asthma pathophysiology includes an inflammatory component has spurred the more aggressive use of anti-inflammatory therapies and created a need for effective tools to measure inflammation. Biomarkers of airway inflammation proposed are obtained by methods that are direct but highly invasive (bronchial biopsy, bronchoalveolar lavage), moderately direct, and less invasive (indirect sputum, exhaled air, breath condensate) or indirect and least invasive (blood, urine). Several studies described in this review have implicated the cysteinyl leukotrienes (CysLTs) as inflammatory mediators in a wide range of diseases, implying that their biological activities reach far beyond acute bronchoconstriction, the activity traditionally ascribed to them. The validity of examining sputum for "biomarkers" has improved the understanding of asthma pathophysiology, optimization of asthma treatment and management, and investigation of the relation between CysLTs and airway inflammation in asthma. Nitric oxide is also a surrogate marker of asthma and reflects airway inflammation. The anti-inflammatory effects of the leukotriene receptor antagonists and the markers of their activity continue to grow.

Original languageEnglish (US)
JournalThe Journal of Allergy and Clinical Immunology
Volume111
Issue number1 SUPPL.
DOIs
StatePublished - Jan 1 2003
Externally publishedYes

Fingerprint

Leukotriene Antagonists
Asthma
Inflammation
Biomarkers
Sputum
Anti-Inflammatory Agents
Bronchoconstriction
Bronchoalveolar Lavage
Nitric Oxide
Air
cysteinyl-leukotriene
Urine
Biopsy
Therapeutics

Keywords

  • Airway inflammation
  • Biomarkers of inflammation
  • Cysteinyl leukotrienes
  • Leukotriene receptor antagonists
  • Nitric oxide

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Sampson, A. P., Pizzichini, E., Bisgaard, H., Moqbel, R., Peters-Golden, M., Peters, S., ... Edelman, J. (2003). Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation. The Journal of Allergy and Clinical Immunology, 111(1 SUPPL.). https://doi.org/10.1067/mai.2003.24

Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation. / Sampson, Anthony P.; Pizzichini, Emilio; Bisgaard, Hans; Moqbel, Redwan; Peters-Golden, Marc; Peters, Stephen; Liu, Mark Chang Hwa; Hamid, Qutayba; Edelman, Jonathan.

In: The Journal of Allergy and Clinical Immunology, Vol. 111, No. 1 SUPPL., 01.01.2003.

Research output: Contribution to journalArticle

Sampson, AP, Pizzichini, E, Bisgaard, H, Moqbel, R, Peters-Golden, M, Peters, S, Liu, MCH, Hamid, Q & Edelman, J 2003, 'Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation', The Journal of Allergy and Clinical Immunology, vol. 111, no. 1 SUPPL.. https://doi.org/10.1067/mai.2003.24
Sampson, Anthony P. ; Pizzichini, Emilio ; Bisgaard, Hans ; Moqbel, Redwan ; Peters-Golden, Marc ; Peters, Stephen ; Liu, Mark Chang Hwa ; Hamid, Qutayba ; Edelman, Jonathan. / Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation. In: The Journal of Allergy and Clinical Immunology. 2003 ; Vol. 111, No. 1 SUPPL.
@article{35d7c1524fc342829e91391a896377a0,
title = "Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation",
abstract = "The understanding that asthma pathophysiology includes an inflammatory component has spurred the more aggressive use of anti-inflammatory therapies and created a need for effective tools to measure inflammation. Biomarkers of airway inflammation proposed are obtained by methods that are direct but highly invasive (bronchial biopsy, bronchoalveolar lavage), moderately direct, and less invasive (indirect sputum, exhaled air, breath condensate) or indirect and least invasive (blood, urine). Several studies described in this review have implicated the cysteinyl leukotrienes (CysLTs) as inflammatory mediators in a wide range of diseases, implying that their biological activities reach far beyond acute bronchoconstriction, the activity traditionally ascribed to them. The validity of examining sputum for {"}biomarkers{"} has improved the understanding of asthma pathophysiology, optimization of asthma treatment and management, and investigation of the relation between CysLTs and airway inflammation in asthma. Nitric oxide is also a surrogate marker of asthma and reflects airway inflammation. The anti-inflammatory effects of the leukotriene receptor antagonists and the markers of their activity continue to grow.",
keywords = "Airway inflammation, Biomarkers of inflammation, Cysteinyl leukotrienes, Leukotriene receptor antagonists, Nitric oxide",
author = "Sampson, {Anthony P.} and Emilio Pizzichini and Hans Bisgaard and Redwan Moqbel and Marc Peters-Golden and Stephen Peters and Liu, {Mark Chang Hwa} and Qutayba Hamid and Jonathan Edelman",
year = "2003",
month = "1",
day = "1",
doi = "10.1067/mai.2003.24",
language = "English (US)",
volume = "111",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "1 SUPPL.",

}

TY - JOUR

T1 - Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation

AU - Sampson, Anthony P.

AU - Pizzichini, Emilio

AU - Bisgaard, Hans

AU - Moqbel, Redwan

AU - Peters-Golden, Marc

AU - Peters, Stephen

AU - Liu, Mark Chang Hwa

AU - Hamid, Qutayba

AU - Edelman, Jonathan

PY - 2003/1/1

Y1 - 2003/1/1

N2 - The understanding that asthma pathophysiology includes an inflammatory component has spurred the more aggressive use of anti-inflammatory therapies and created a need for effective tools to measure inflammation. Biomarkers of airway inflammation proposed are obtained by methods that are direct but highly invasive (bronchial biopsy, bronchoalveolar lavage), moderately direct, and less invasive (indirect sputum, exhaled air, breath condensate) or indirect and least invasive (blood, urine). Several studies described in this review have implicated the cysteinyl leukotrienes (CysLTs) as inflammatory mediators in a wide range of diseases, implying that their biological activities reach far beyond acute bronchoconstriction, the activity traditionally ascribed to them. The validity of examining sputum for "biomarkers" has improved the understanding of asthma pathophysiology, optimization of asthma treatment and management, and investigation of the relation between CysLTs and airway inflammation in asthma. Nitric oxide is also a surrogate marker of asthma and reflects airway inflammation. The anti-inflammatory effects of the leukotriene receptor antagonists and the markers of their activity continue to grow.

AB - The understanding that asthma pathophysiology includes an inflammatory component has spurred the more aggressive use of anti-inflammatory therapies and created a need for effective tools to measure inflammation. Biomarkers of airway inflammation proposed are obtained by methods that are direct but highly invasive (bronchial biopsy, bronchoalveolar lavage), moderately direct, and less invasive (indirect sputum, exhaled air, breath condensate) or indirect and least invasive (blood, urine). Several studies described in this review have implicated the cysteinyl leukotrienes (CysLTs) as inflammatory mediators in a wide range of diseases, implying that their biological activities reach far beyond acute bronchoconstriction, the activity traditionally ascribed to them. The validity of examining sputum for "biomarkers" has improved the understanding of asthma pathophysiology, optimization of asthma treatment and management, and investigation of the relation between CysLTs and airway inflammation in asthma. Nitric oxide is also a surrogate marker of asthma and reflects airway inflammation. The anti-inflammatory effects of the leukotriene receptor antagonists and the markers of their activity continue to grow.

KW - Airway inflammation

KW - Biomarkers of inflammation

KW - Cysteinyl leukotrienes

KW - Leukotriene receptor antagonists

KW - Nitric oxide

UR - http://www.scopus.com/inward/record.url?scp=0037246224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037246224&partnerID=8YFLogxK

U2 - 10.1067/mai.2003.24

DO - 10.1067/mai.2003.24

M3 - Article

C2 - 12532086

AN - SCOPUS:0037246224

VL - 111

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 1 SUPPL.

ER -